September 18, 2017 / 12:29 PM / in a month

BRIEF-CTD Holdings announces approval of clinical trial application

Sept 18 (Reuters) - CTD Holdings Inc

* CTD Holdings announces approval of clinical trial application to conduct Phase I/II clinical study of trappsol(R) cyclo(TM) in patients with Niemann-pick Type C disease in Israel Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below